Parties d'ouvrages collectifs (2)
  1. 1. Englert, Y., Vekemans, M., Lejeune, B., Van Rysselberge, M., De Maertelaer, G., & Leroy, F. (1988). Etude de la valeur pronostique des spermogrammes de consultation sur l'issue des essais de fécondation in vitro. In R. Schoysman (Ed.), A la recherche du pouvoir fécondant du sperme (pp. 161-170). Palerme.
  2. 2. Robyn, C., Delvoye, P., Van Exter, C., Vekemans, M., Caufriez, A., De Nayer, P., Delogne-Desnoeck, J., & L'Hermite, M. (1977). Physiological and pharmacological factors influencing prolactin secretion and their relation to human reproduction. In Crosignani & C. Robyn (Eds.), Prolactin and Human Reproduction (pp. 71-96). London & New York: Academic Press.
    3.   Articles dans des revues avec comité de lecture (42)
  3. 1. Vekemans, M., Robinson, J., Georgala, A., Heymans, C., Muanza, F., Paesmans, M., Klastersky, J., Barette, M., Meuleman, N., Huet, F., Calandra, T., Costantini, S., Ferrant, A., Mathissen, F., Axelsen, M., Marchetti, O., & Aoun, M. (2007). Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clinical infectious diseases, 44(12), 1593-1601. doi:10.1086/518171
  4. 2. Galant, C., Vekemans, M., Lemoine, P., Kokorine, I., Twagirayezu, P., Henriet, P., Picquet, C., Rigot, V., Eeckhout, Y., Courtoy, P., & Marbaix, E. (2000). Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. The Journal of clinical endocrinology and metabolism, 85(12), 4827-4834. doi:10.1210/jc.85.12.4827
  5. 3. Marbaix, E., Sufi, S., Eeckhout, Y., Courtoy, P., Vekemans, M., Galant, C., Rigot, V., Lemoine, P., Dubois, D., Picquet, C., Henriet, P., & Twagirayezu, P. (2000). Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users. Human reproduction, 15, 120-134. doi:10.1093/humrep/15.suppl_3.120
  6. 4. Vekemans, M., & Verougstraete, A. (1999). Late uterine perforation with an anchored IUD, the Gynefix®: A case report. Contraception, 60(1), 55-56. doi:10.1016/S0010-7824(99)00055-4
  7. 5. Vekemans, M. (1998). Progres recents en contraception. Revue médicale de Bruxelles, 19(4), A175-A180.
  8. 6. Vekemans, M., Delvigne, A., & Paesmans, M. (1997). Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant®): A prospective study in Belgium. Contraception, 56(5), 291-299. doi:10.1016/S0010-7824(97)00155-8
  9. 7. Vekemans, M. (1997). Postpartum contraception: The lactational amenorrhea method. European journal of contraception & reproductive health care, 2(2), 105-111.
  10. 8. Humblet, C. P., Vekemans, M., & Buekens, P. (1996). Developments in abortion policy in a context of illegality: the Belgian case from 1971 until 1990. European Journal of Public Health, 6(4), 288-293.
  11. 9. Vekemans, M., Delvigne, A., & Paesmans, M. (1996). Continuite d'utilisation d'un implant contraceptif au levonorgestrel: Etude prospective en Belgique. Revue médicale de Bruxelles, 17(6), 375-381.
  12. 10. Humblet, C. P., Dujardin, B., Vekemans, M., & Buekens, P. (1995). Termination of pregnancy applications: psycho-social factors in a context of illegal practice. Archives of Public Health, 53(9-10), 443-459.
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>